Viewing Study NCT06525012



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06525012
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-24

Brief Title: Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021
Sponsor: None
Organization: None

Study Overview

Official Title: Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HSA Rankin
Brief Summary: The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique Predictive factors of poor prognosis will also be analyzed
Detailed Description: Subarachnoid hemorrhage is an uncommon pathology in the general population with a worldwide incidence of 9 per 100000 peopleyear but with a non-negligible risk of sequelae in terms of impairments activity limitations and participation restrictions of around 30 Mortality remains high at 40 despite increasingly specialized care

In addition there are a number of objective rapid assessment scores for autonomy and impairments notably the modified Rankin score which is not specific to subarachnoid hemorrhage but which enables the study of patients perceived quality of life Certain factors predictive of bad patient outcome are known in the literature but have been little studied in the population of Martinique

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None